Globus Medical, Inc.
GMED
株式のランク
#1984
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
株価
$79.05
最終同期: 2026-10-20
時価総額
$10.61B
変化（1日）
4.29%
変化（1年）
26.02%
国
US
取引 Globus Medical, Inc. (GMED)
カテゴリー
Healthcare
Globus Medical, Inc.（GMED）の利益
Jun 2026 時点の利益 TTM: $664.95M
Globus Medical, Inc. の最新の財務報告によると、同社の現在の利益は $664.95M です。2023 年には $165.39M の利益を上げ、これは 2022 年の利益 $243.02M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Globus Medical, Inc. の利益の推移（2009 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $664.95M | 450.81% |
| 2024 | $120.72M | -27.01% |
| 2023 | $165.39M | -31.94% |
| 2022 | $243.02M | 34.71% |
| 2021 | $180.41M | 43.30% |
| 2020 | $125.90M | -33.72% |
| 2019 | $189.95M | 0.71% |
| 2018 | $188.61M | 10.99% |
| 2017 | $169.93M | 8.04% |
| 2016 | $157.28M | -8.98% |
| 2015 | $172.81M | 24.64% |
| 2014 | $138.64M | 35.92% |
| 2013 | $102.00M | -11.04% |
| 2012 | $114.65M | 18.26% |
| 2011 | $96.95M | 10.50% |
| 2010 | $87.74M | 7.29% |
| 2009 | $81.78M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| $7.51B | 1,029.56% |
US
|
|
| $5.56B | 736.60% |
IE
|
|
| $5.15B | 674.19% |
US
|
|
| $3.86B | 480.65% |
US
|
|
| - | - |
DE
|
